Delve Bio
Health Care
Overview
Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Funding and backers
Total raised
$35M
1 round on record
Latest round
$35M
Venture round · Jun 2023 · 3 yr ago
Backers
2
Xontogeny, GV
The money's age
Long since its last round
40 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 4, 2024
Launched Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect · businesswire.com
Jun 27, 2023
Raised a round Venture round $35M · Pulse 2.0
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2023 | $35M | — | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny 
GV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…
SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and…
Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious…
Strengthening global capacity to improve health outcomes and mitigate infectious disease threats. Metabiota strives to protect lives and to…
Biotia is advancing infectious disease diagnostics for patients managing challenging infections. Learn more about our work.
Financials
Total raised
$35M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $35M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Stumped by a Medical Mystery? Try Metagenomics
Jason Liebowitz on metagenomics, a new and powerful type of genetic testing that can search for thousands of different microorganisms in a single sweep to vastly speed up the diagnosing of uncommon infections.
Read more
Report
Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails
BOSTON, April 16, 2026--Delve Bio announces data showing Delve Detect enables neurologists to treat CNS infections when conventional testing fails at AAN Annual Meeting
Read more
Report
Delve Bio Continues to Bolster Data on Metagenomic Sequencing Utility for Diagnosing CNS Infections
A newly published study modeling the impact of clinical metagenomic NGS testing suggests earlier diagnosis and significant cost savings for patients and providers.
Read more
Report
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio's Metagenomic Sequencing Test for Improving CNS Diagnosis
BOSTON, November 14, 2025--Presentations at AMP 2025 show utility of Delve Detect for diagnosing complex CNS infections, such as co-infection and culture-negative presentations
Read more
Report
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio's Metagenomic Sequencing Test for Improving CNS Diagnosis
Read more
Report
New Data Show Early Use of Delve Bio's Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis
Read more
Report
Delve Bio Reduces Turnaround Time for Agnostic Pathogen Detection Service
The company has reduced the turnaround time to a little over 48 hours for its pathogen-agnostic metagenomic next-generation sequencing test service for CNS infections.
Read more
Report
Daily News
The Los Angeles Daily News is the local news source for Los Angeles and the San Fernando Valley region, providing breaking news, sports, business, entertainment, things to do, opinion, photos, videos and more from L.A.
Read more
Report
Opinion The free-living bureaucrat
Michael Lewis on Heather Stone of the Food and Drug Administration.
Read more
Report
Show more news